iBio updates corporate presentation; no financial or operational specifics disclosed

iBio, Inc.

Filed updated investor presentation dated June 2024 under Item 7.01.
Presentation title: 'Tomorrow's Precision Antibody Therapeutics Powered by Machine Learning'.
No new financial data, guidance, or material business changes were included in the filing.
The presentation is furnished, not filed, and not incorporated by reference.
No forward-looking statements or new milestones were provided beyond prior disclosures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.